SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-285901
Filing Date
2019-11-06
Accepted
2019-11-06 16:10:12
Documents
22
Period of Report
2019-11-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823801d8k.htm   iXBRL 8-K 26865
2 EX-99.1 d823801dex991.htm EX-99.1 9699
6 GRAPHIC g823801ex99_1s1g1.jpg GRAPHIC 186158
7 GRAPHIC g823801ex99_1s2g1.jpg GRAPHIC 457128
8 GRAPHIC g823801ex99_1s3g1.jpg GRAPHIC 332452
9 GRAPHIC g823801ex99_1s4g1.jpg GRAPHIC 247914
10 GRAPHIC g823801ex99_1s5g1.jpg GRAPHIC 257905
11 GRAPHIC g823801ex99_1s6g1.jpg GRAPHIC 198012
12 GRAPHIC g823801ex99_1s7g1.jpg GRAPHIC 228090
13 GRAPHIC g823801ex99_1s8g1.jpg GRAPHIC 237687
14 GRAPHIC g823801ex99_1s9g1.jpg GRAPHIC 259932
  Complete submission text file 0001193125-19-285901.txt   3477063

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aeri-20191106.xsd EX-101.SCH 3079
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20191106_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20191106_pre.xml EX-101.PRE 11414
20 EXTRACTED XBRL INSTANCE DOCUMENT d823801d8k_htm.xml XML 3420
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36152 | Film No.: 191196384
SIC: 2836 Biological Products, (No Diagnostic Substances)